| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 30-Sep-08 | | Total Revenue |
-
|
-
|
-
| 13 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
| 13 | | | Operating Expenses | | Research Development | 5,978 | 5,813 | 4,668 | 5,004 | | Selling General and Administrative | 1,762 | 2,362 | 1,965 | 2,234 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (7,740) | (8,175) | (6,633) | (7,225) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 797 | 209 | 58 | 116 | | Earnings Before Interest And Taxes | (6,943) | (7,966) | (6,575) | (7,109) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (6,943) | (7,966) | (6,575) | (7,109) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | (9,914) | 3,717 |
-
|
-
| | | | Net Income From Continuing Ops | (16,857) | (4,249) | (6,575) | (7,109) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (16,857) | (4,249) | (6,575) | (7,109) | | Preferred Stock And Other Adjustments |
-
| (1,023) | 1,023 |
-
| | | Net Income Applicable To Common Shares | ($16,857) | ($5,272) | ($5,552) | ($7,109) |
|
0.51% Nasdaq 
Income Statement
